Finemedix Co., Ltd.
KKRX:3875705,800.00
KRW
-140.00
(-2.36%)
ISIN
KR7387570005
Return %
Stock
S&P 500
1Y
-29.10
14.39
3Y
- -
81.42
5Y
- -
68.62
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Seong-Woo Jeon
- Full Time Employees
- 77
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Daegu South Korea
- IPO Date
- Dec 26, 2024
- Website
- finemedix.com
- Similar Companies
- Business
- Finemedix Co., Ltd. is a South Korea-based medical device manufacturer primarily engaged in the research, development, production, and commercialization of minimally invasive gastrointestinal endoscopic surgical instruments and diagnostic devices. Founded in 2009 and headquartered in Daegu, South Korea, the company operates within the healthcare equipment and supplies industry, serving general hospitals, university medical centers, and specialized endoscopy clinics worldwide through a clinician-collaborative development model. The company's core product portfolio encompasses a comprehensive range of therapeutic and diagnostic endoscopic solutions: Endoscopic Submucosal Dissection (ESD) and Endoscopic Mucosal Resection (EMR) instruments, comprising the proprietary ClearCut Knife series (including H/H2 hybrid needle-and-tip knives, I-type marking and dissection knives, J Plus integrated water-jet injection knives, Mini insulated knives, and Q-type multi-edge knives) alongside electrosurgical polypectomy snares; endoscopic biopsy and tissue sampling devices, including Clear-Accu, Clear-Bite, and Endo-bite disposable biopsy forceps; hemostasis and injection systems, including ClearEndoClip mechanical clipping devices, ClearCoajet dual-action injection and coagulation catheters, and endoscopic sclerotherapy needles; Endoscopic Ultrasound (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP) instruments, including ClearTip Fine Needle Aspiration (FNA) and Fine Needle Biopsy (FNB) needles, FineTome sphincterotomes, stone retrieval baskets, and guidewires; and endoscopic accessory tools, including ClearCap distal endoscopic attachment caps, dilation balloons, and polyp traps. The company also offers original design manufacturing (ODM) and custom development services for global medical device partners. Finemedix conducts operations across South Korea and exports to international markets spanning Europe, North America, the Asia-Pacific region, and Latin America. In recent corporate developments, the company completed its initial public offering on the KOSDAQ market under the ticker 387570. In operational and regulatory advancements, Finemedix obtained European Union Medical Device Regulation (CE MDR) certification for seven core endoscopic product lines, enabling direct commercial access across thirty European Economic Area countries. The company also secured medical device marketing approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its ClearCut Knife line, becoming the first South Korean manufacturer to enter the Japanese ESD knife market, while maintaining United States Food and Drug Administration (FDA) 510(k) clearances and Brazil ANVISA registrations to support ongoing overseas distribution and ODM contract expansions.